Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance
Wakatsuki, A.; Okatani, Y.; Fukaya, T.
Circulation 107(20): E197; Author Reply E197
2003
ISSN/ISBN: 0009-7322 PMID: 12777328 DOI: 10.1161/01.cir.0000074255.39417.9fDocument Number: 243363
Document emailed within 0-6 h
Related Documents
Lizarelli, P.íc.M.; Martins, W.P.; Vieira, C.S.; Soares, G.M.; Franceschini, S.íl.A.ôn.; Ferriani, R.A.; Patta, M.C. 2009: Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women Contraception 79(1): 35-40Modesto, W.; Bahamondes, M.V.; Bahamondes, L. 2015: Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate Journal of Women's Health 24(8): 636-640
Mettler, L.; Shirwani, D.; Brunnberg, F.J. 1979: Thombocyte function in relation to the long term application of medroxyprogesterone acetate as a female contraceptive agent Journal of Postgraduate Medicine 25(3): 154-157
Cundy, T.; Cornish, J.; Roberts, H.; Reid, I.R. 2002: Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception American Journal of Obstetrics and Gynecology 186(5): 978-983
Lali, P.; Chandra, L.; Gupta, R.P. 1996: Serum immunoglobulin levels during contraceptive use of depot-medroxyprogesterone acetate in Indian women: A preliminary study Contraception 53(6): 363-365
Cheewadhanaraks, S. 2013: Cumulative recurrence rates of endometriosis-associated pain after long-term intramuscular depot medroxyprogesterone acetate therapy Journal of the Medical Association of Thailand 96(2): 140-143
Harris, T.G.; Miller, L.; Kulasingam, S.L.; Feng, Q.; Kiviat, N.B.; Schwartz, S.M.; Koutsky, L.A. 2009: Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection American Journal of Obstetrics and Gynecology 200(5): 489.E1-8
Cuong, D.T.; My Huong, N.T. 1996: Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and cyclofem, in Vietnamese women Contraception 54(3): 169-179
Haddad, L.B.; Cwiak, C.; Jamieson, D.J.; Feldacker, C.; Tweya, H.; Hosseinipour, M.; Hoffman, I.; Bryant, A.G.; Stuart, G.S.; Noah, I.; Mulundila, L.; Samala, B.; Mayne, P.; Phiri, S. 2013: Contraceptive adherence among HIV-infected women in Malawi: a randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate Contraception 88(6): 737-743
el-Mahgoub, S.; Karim, M.; Ammar, R. 1972: Long-term use of depot medroxy progesterone acetate as a contraceptive Acta Obstetricia et Gynecologica Scandinavica 51(3): 251-255
Tharnprisarn, W.; Taneepanichskul, S. 2002: Bone mineral density in adolescent and young Thai girls receiving oral contraceptives compared with depot medroxyprogesterone acetate: A cross-sectional study in young Thai women Contraception 66(2): 101-103
Jeppsson, S.; Gershagen, S.; Johansson, E. D. B.; Rannevik, G. 1982: Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera(R)) as a contraceptive agent European Journal of Endocrinology 99(3): 339-343
Wong, A.Y.K.; Tang, L.C.H.; Chin, R.K.H. 2010: Levonorgestrel-releasing intrauterine system (Mirena) and Depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial Australian and New Zealand Journal of Obstetrics and Gynaecology 50(3): 273-279
Zia, Y.; Tang, J.H.; Chinula, L.; Tegha, G.; Stanczyk, F.Z.; Kourtis, A.P. 2019: Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi Contraception 100(5): 402-405
Bloch, B. 1971: Depot medroxyprogesterone acetate (Depo-Provera) as a contraceptive preparation South African Medical Journal 45(28): 777-780
Chaudhri, R.; Rizvi, F.; Afzal, M. 2010: Patient satisfaction of depot medroxyprogesterone acetate (dmpa-sc) injection as contraceptive Jpma. Journal of the Pakistan Medical Association 60(7): 536-540
Hu, E.; Ikeako, L.C.; Obiora-Okafor, N.C. 2012: The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria 21(3): 266-271
Hu, E.; Ikeako, L.C.; Obiora-Okafor, N.C. 2012: The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria 21(3): 266-271
Kaunitz, A.M. 1994: Long-acting injectable contraception with depot medroxyprogesterone acetate American Journal of Obstetrics and Gynecology 170(5 Pt 2): 1543-1549
Cursino, K.; Sider, M.; Pavin, E.J.ão.; dos Santos, P.d.N.é S.; Bahamondes, L.; Zantut-Wittmann, D.E.; Fernandes, A. 2016: Insulin resistance parameters in users of the injectable contraceptive depot medroxyprogesterone acetate during one year of use European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 21(1): 22-29